CA
TBI

Clearstead Advisors’s Trueblue TBI Stock Holding History

Clearstead Advisors’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7 Buy
+1
New +$6 ﹤0.01% 3637

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Clearstead Advisors's TBI Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Trueblue (TBI) in Q2 2026: 1 share worth $7. The stake represents ﹤0.01% of the portfolio and ranks #3637 among its holdings.

39 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Clearstead Advisors held 1 share of Trueblue worth $7 as of Q2 2026.
  • Trueblue was a new Clearstead Advisors position in Q2 2026.
  • Trueblue made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3637 holding.
  • 39 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.